Non-intensive treatment strategies in AML
EHA Library. Ossenkoppele G. 06/16/18; 219195 Topic: 2B Acute myeloid leukemia (AML) and leukemias of ambiguous lineage
Dr. Gert Ossenkoppele
Dr. Gert Ossenkoppele
Contributions
Learning Objectives
• describe current and emerging non-intensive treatment strategies in AML,
• select appropriate upfront therapy based upon patient and disease characteristics, and
• discuss new targeted treatment options for patients who are not suitable for intensive treatment.

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies